Open AccessPlasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy
Author(s) -
Dayong Wang,
Xiangqing Hou,
Xianghua Yu,
Tao Wang,
Zhenmiao Ye,
Jushuang Li,
Feifei Su,
Chengnan Guo,
Fang Peng,
Shuzhen Zhao,
Huihui Li,
Jingjing Zuo,
Dehua Su,
Lina Zhao,
Hemei Zhang,
Xiangyang Chen,
Ruoqiu Wang,
Qipeng Xie,
Zheng Cheng,
Guangyun Mao
Publication year - 2021
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.202987
Subject(s) - antiretroviral therapy , medicine , human immunodeficiency virus (hiv) , hemoglobin , virology , viral load
Previous studies concerning the effect of plasma hemoglobin (HB) and other factors that may modify the risk of death in people living with HIV/AIDS (PLHIV) treated with antiretroviral therapy (ART) are limited.